Institution scientifique

ZZN Pelhřimov (Czechia)

Pelhřimov · CZ · company

65Publications signalées

737Citations signalées

12Thèmes principaux

Principaux domaines

Multiple Myeloma Research and TreatmentsCancer Treatment and PharmacologyPeptidase Inhibition and AnalysisAcute Myeloid Leukemia ResearchHip and Femur FracturesProtein Degradation and InhibitorsOrthopaedic implants and arthroplastyChronic Lymphocytic Leukemia ResearchAmyloidosis: Diagnosis, Treatment, OutcomesLymphoma Diagnosis and TreatmentRadiation Dose and ImagingChronic Myeloid Leukemia Treatments

Évolution annuelle

1894 1

1970 1

1990 4

1991 4

1995 1

1997 1

2004 1

2006 1

2007 1

2008 2

2009 1

2011 1

2012 1

2013 2

2014 5

2015 4

2016 6

2017 4

2018 2

2019 5

2020 4

2021 5

2022 2

2023 2

2025 2

2026 2

Publications récentes

Accès ouvert 2026 articleOpenAlex

P25 | REAL-WORLD OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA: EVIDENCE SUPPORTING BORTEZOMIB–LENALIDOMIDE–DEXAMETHASONE AS A PREFERRED REGIMEN WITHOUT ANTI-CD38 ANTIBODIES

A. Jungova, M. Stork, I Spicka, J. Radocha et autres

0 citationsHaematologica

Accès ouvert 2026 articleOpenAlex

P75 | CURRENT STATUS OF REGISTRY OF MONOCLONAL GAMMOPATHIES - THE CZECH MYELOMA GROUP "REAL WORLD“ DATABASE

V. Maisnar, Luděk Pour, I Spicka, J. Minarik et autres

0 citationsHaematologica

2025 articleOpenAlex

Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies

Alexandra Jungová, Martin Štork, Ivan Špıčka, Jakub Radocha et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

Accès ouvert 2025 conference-abstractOpenAlex

Validation of novel prognostic models in symptomatic Waldenström's macroglobulinemia based on real-world data

Michal Kaščák, Prokop Vodička, S. J. Martin, Zdeněk Adam et autres

0 citationsBlood

Accès ouvert 2023 articleOpenAlex

Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies

Viera Sandecká, Tereza Popková, Martin Štork, Vladimír Maisnar et autres

8 citationsBlood Cancer Journal

Accès ouvert 2023 articleOpenAlex

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group

Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová et autres

6 citationsAnnals of Hematology

Accès ouvert 2022 articleOpenAlex

Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection inrare disease

Erika Tarasco, Anne Sophie von Krogh, Radomíra Hrdličková, Thomas R. Braschler et autres

7 citationsResearch and Practice in Thrombosis and Haemostasis

Accès ouvert 2022 articleOpenAlex

Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data

Viera Sandecká, Luděk Pour, Ivan Špıčka, Jiří Minařík et autres

2 citationsNeoplasma

Accès ouvert 2021 articleOpenAlex

Impact of the COVID-19 pandemic on nuclear medicine departments in Europe

Ana Paula Moreira, François Jamar, Zehra Özcan, Doina Piciu et autres

6 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

2021 articleOpenAlex

Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data

Viera Sandecká, Luděk Pour, Ivan Špıčka, Jiří Minařík et autres

3 citationsEuropean Journal Of Haematology

2021 articleOpenAlex

Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real‐world confirmation

Jakub Radocha, Tomáš Jelı́nek, Luděk Pour, Ivan Špıčka et autres

3 citationsInternational Journal of Laboratory Hematology

Accès ouvert 2021 articleOpenAlex

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

Jiří Minařík, Tomáš Pika, Jakub Radocha, Alexandra Jungová et autres

33 citationsBMC Cancer

Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.